Ophthalmic Solution in Diabetic Corneal Alteration

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

September 1, 2021

Primary Completion Date

September 1, 2022

Study Completion Date

September 1, 2022

Conditions

Dry Eye Disease (DED)

Interventions

DEVICE

CX-HA and CS

Sterile Isotonic ophthalmic solution

Trial Locations (1)

San Giovanni-Addolorata Hospital, Rome

All Listed Sponsors

collaborator

San Giovanni Addolorata Hospital

OTHER

lead

D&V FARMA srl

INDUSTRY

NCT06573606 - Ophthalmic Solution in Diabetic Corneal Alteration | Biotech Hunter | Biotech Hunter